PROVOLUT Trademark

Trademark Overview


On Thursday, July 3, 2025, a trademark application was filed for PROVOLUT with the United States Patent and Trademark Office. The USPTO has given the PROVOLUT trademark a serial number of 99266882. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, February 24, 2026. This trademark is owned by Exazyme GmbH. The PROVOLUT trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

IT services, namely, IT consulting services relating to the implementation, integration, maintenance, and customization of software for computational biology, protein engineering, and drug design; development, programming and implementation of software for others; hosting services, namely, hosting cloud-based software platforms for computational protein design, molecular simulation, and drug discovery; platform-as-a-service (PaaS) featuring computer software platforms for computational protein engineering, machine-learning-driven protein optimization, and pharmaceutical drug candidate design and analysis; software-as-a-service (SaaS) services featuring software for AI-driven protein design, protein optimization, molecular engineering, and drug discovery; rental of computer software for computational protein design, protein optimization, molecular simulation, and drug development; design and development of computer hardware and software; scientific and technological services, namely, sc...

Recorded and downloadable media and data, namely, recorded and downloadable datasets comprising protein sequence, structure, and function data for use in biotechnology and pharmaceutical research; Downloadable databases in the field of protein engineering, molecular biology, and drug discovery; Downloadable software for computational protein design, protein engineering, molecular simulation, and optimization of proteins, enzymes, and molecules for pharmaceutical and industrial biotechnology applications; Downloadable artificial intelligence software for protein design, protein optimization, drug candidate identification, and prediction of protein properties and downloadable software using machine learning for designing, analyzing, optimizing, and predicting the function and properties of proteins, enzymes, and molecules for use in pharmaceutical development and biotechnology; all the aforesaid goods relating to, in particular, synthetic biology, biotechnology, protein engineering, mole...
provolut

General Information


Serial Number99266882
Word MarkPROVOLUT
Filing DateThursday, July 3, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, February 24, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesIT services, namely, IT consulting services relating to the implementation, integration, maintenance, and customization of software for computational biology, protein engineering, and drug design; development, programming and implementation of software for others; hosting services, namely, hosting cloud-based software platforms for computational protein design, molecular simulation, and drug discovery; platform-as-a-service (PaaS) featuring computer software platforms for computational protein engineering, machine-learning-driven protein optimization, and pharmaceutical drug candidate design and analysis; software-as-a-service (SaaS) services featuring software for AI-driven protein design, protein optimization, molecular engineering, and drug discovery; rental of computer software for computational protein design, protein optimization, molecular simulation, and drug development; design and development of computer hardware and software; scientific and technological services, namely, scientific research, computational analysis, and testing in the field of protein engineering, molecular biology, drug discovery, and biotechnology and scientific and technological research in the field of protein design, enzyme engineering, drug development, and precision oncology and design services relating thereto, namely, computational protein design, enzyme design, drug candidate design, and software design for biotechnology applications; industrial research in the field of biotechnology, protein engineering, and industrial enzyme development and industrial design services; quality control of goods and services and authentication in the field of protein and enzyme quality, pharmaceutical drug candidates, and biotechnological products; development of pharmaceutical products; Scientific laboratory services; laboratory research in the field of protein engineering, molecular biology, enzyme optimization, and pharmaceutical drug development; Scientific laboratory services; Computer software consultancy, information and information services in the field of computational biology, protein engineering, drug design, and biotechnology relating to the aforementioned services; all of the aforementioned services, in particular, in the field of synthetic biology, biotechnology, protein technology, molecular sciences and for the design, development and optimization of proteins, enzymes and molecules
Goods and ServicesRecorded and downloadable media and data, namely, recorded and downloadable datasets comprising protein sequence, structure, and function data for use in biotechnology and pharmaceutical research; Downloadable databases in the field of protein engineering, molecular biology, and drug discovery; Downloadable software for computational protein design, protein engineering, molecular simulation, and optimization of proteins, enzymes, and molecules for pharmaceutical and industrial biotechnology applications; Downloadable artificial intelligence software for protein design, protein optimization, drug candidate identification, and prediction of protein properties and downloadable software using machine learning for designing, analyzing, optimizing, and predicting the function and properties of proteins, enzymes, and molecules for use in pharmaceutical development and biotechnology; all the aforesaid goods relating to, in particular, synthetic biology, biotechnology, protein engineering, molecular sciences and the design, development and optimization of proteins, enzymes and molecules

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, July 3, 2025
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 3, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameExazyme GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressBerlin 13355
DE

Trademark Events


Event DateEvent Description
Thursday, July 3, 2025NEW APPLICATION ENTERED
Thursday, July 3, 2025APPLICATION FILING RECEIPT MAILED
Sunday, November 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 21, 2025ASSIGNED TO EXAMINER
Monday, November 24, 2025NON-FINAL ACTION WRITTEN
Monday, November 24, 2025NON-FINAL ACTION E-MAILED
Monday, November 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 24, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 24, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 24, 2026TEAS/EMAIL CORRESPONDENCE ENTERED